Grandview Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Grandview Asset Management's LLY Position: Q1 2026 in Review
Grandview Asset Management increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $260K and bringing the position to 1,807 shares worth $1.66M. The position accounts for 0.49% of the portfolio, ranked #45.
Grandview Asset Management first reported a position in LLY in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.67M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Grandview Asset Management held 1,807 shares of Eli Lilly worth $1.66M as of Q1 2026.
- Grandview Asset Management bought 256 Eli Lilly shares in Q1 2026, an estimated $260K.
- Eli Lilly made up 0.49% of Grandview Asset Management's portfolio in Q1 2026, its #45 holding.
- Grandview Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 9 quarters since.
- Grandview Asset Management's Eli Lilly position peaked at $1.67M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Grandview Asset Management's 13F filing for Q1 2026, filed 7 May 2026.